Features | Partner Sites | Information | LinkXpress
Sign In
TeraRecon
VIEWORKS
Schiller

Cancer Therapy Efficacy May Be Determined Using MRI and Oxygen

By Medimaging International staff writers
Posted on 30 Jun 2009
Utilizing a simple magnetic resonance imaging (MRI) scan involving breathing oxygen might help oncologists determine the best treatment for some cancer patients, reported researchers.

Earlier studies have shown that the amount of oxygen present in a tumor can be a predictor of how well a patient will respond to treatment. Tumors with little oxygen tend to grow stronger and resist both radiotherapy and chemotherapy. Until now, however, the only way to measure the oxygen level in a tumor, and thus determine which treatment might be more effective, was to insert a huge needle directly into the cancerous tumor.

The new technique, known as blood oxygen level-dependent (BOLD) MRI, can detect oxygen levels in tumors without the need for an invasive procedure. The patient need only be able to breathe in oxygen when undergoing an MRI. "The patient simply inhales pure oxygen, which then circulates through the bloodstream, including to the tumors,” said Dr. Ralph Mason, professor of radiology at the University of Texas (UT) Southwestern Medical Center (Dallas, USA), director of the UT Southwestern Cancer Imaging Center, and senior author of a study appearing online in June 2009 in an issue of the journal Magnetic Resonance in Medicine (MRM). "Using MRI, we can then go in and estimate how much oxygen a particular tumor is taking up, providing us some insight into how the tumor is behaving and what sort of treatment might be effective.”

The most significant finding, according to Dr. Mason, is that BOLD MRI performed as well as the standard yet more invasive procedure for viewing tumors. That method, known as fluorocarbon relaxometry using echo planar imaging for dynamic oxygen mapping (FREDOM) MRI, requires the injection of a chemical called a reporter molecule directly into the tumor. "The BOLD technique appears to indicate accurately the oxygen levels in tumors,” Dr. Mason said. "Because BOLD is immediately applicable to patients, this holds promise as a new method for predicting response to therapy.”

BOLD MRI has been used extensively in studying brain function, but the procedure has only recently begun to be used to assess blood oxygenation and vascular function in tumors. Physicians at UT Southwestern are already evaluating BOLD MRI in patients with cervical, prostate, and head and neck cancer. They have proposed using it in lung cancer patients as well, reported Dr. Mason. Earlier research has shown that those specific tumor types are more likely to have little oxygen.

In the published study, researchers captured multiple images of breast tumors implanted just below the skin of rats, which were given anesthesia to help them remain still during the imaging process. Humans do not require anesthesia, according to Dr. Mason.

Dr. Mason reported that the team took the research back to the preclinical stage because they needed to better define what physicians were seeing in the clinic and whether the findings were reproducible. He reported that examining each form of cancer in this way presents its own technical challenges. For example, the motion of the lungs or the design of a facemask for breathing oxygen must be taken into account. "If we can prove that the test is meaningful in animals, then it is that much more worthwhile to argue for doing it in a patient. This preclinical work provides the foundation for future clinical studies,” Dr. Mason said. "It helps justify doing a larger clinical trial with the goal of ultimately becoming a diagnostic test for oncologists.”

Researchers currently are trying to determine how much oxygen must be inhaled by a patient in order to be effective. The next step is to expand studies in patients and validate the relevance to more tumor types.

Related Links:
University of Texas Southwestern Medical Center


Channels

Radiography

view channel

Detecting Coronary Artery Disease Before Symptoms Appear

Results of a new study aimed to find ways to detect subclinical Cardiovascular Disease (CD) even before symptoms become apparent has been published in the March 24th issue of the Journal of the American College of Cardiology. The study was led by researchers at the Icahn School of Medicine at Mount Sinai Hospital (ISMMS;... Read more

Ultrasound

view channel

Portable Ultrasound Saves Lives in Remote Rural Central America

According to the World Health Organization (WHO; Geneva, Switzerland) over 60% of the world’s population has no access to diagnostic medical imaging such as ultrasound. To address the problem, Floating Doctors, a nonprofit, humanitarian organization in rural Central America and Haiti, uses open boats to provide healthcare... Read more

Nuclear medicine

view channel

PET/CT Dramatically More Effective at Diagnosing Heart Problems Than SPECT

Results of a study that compares the effectiveness of two heart imaging technologies, Single Photon Emission Computed Tomography (SPECT), and coronary-specific Positron Emission Tomography (cardiac PET/CT) have been presented at the 64th American College of Cardiology (ACC; Washington DC, USA) annual Scientific Session... Read more

General/Advanced Imaging

view channel
Image: Measuring the Magnetic Activity in the Brain of a Child, Using a MEG machine. (Photo courtesy of Children\'s Hospital of Philadelphia).

Study Suggests Language Delay Linked to Chromosome Deletion in Children with Neurological Disorders

A study found that children with neuro-developmental problems born with DNA duplications or deletions on part of chromosome 16, show measurable delays in their ability to process sound and language.... Read more

Imaging IT

view channel

New Release of Image Management and Advanced Visualization Solution Unveiled at ECR 2015

A new version of an enterprise medical image management and advanced visualization solution has been launched at the 2015 European Congress of Radiology (ECR) in Vienna (Austria). The visualization solution provider also released new processing capabilities for cardiac Magnetic Resonance (MR), optimized low-dose workflow... Read more

Industry News

view channel

Analysis of Worldwide CT Scanner Sector Released

A report by Kalorama Information (New York, NY, USA) analyzing the global Computed Tomography (CT) market has been published. The report surveyed the CT market outlook until 2018, and the drivers behind the changes. The report investigated CT market sizing, market forecast to 2018, analysis of trends, how the market... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.